Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Holzbeierlein

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Urology|February 10, 2025
Reply: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 AmendmentJeffrey M Holzbeierlein
Nature Clinical Practice. Oncology|November 1, 2007
What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?Jeffrey M Holzbeierlein
The Urologic Clinics of North America|April 25, 2006
Managing complications of androgen deprivation therapy for prostate cancerJeffrey M Holzbeierlein
Cancer|January 26, 2011
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancerJeffrey M Holzbeierlein
The Journal of Urology|August 11, 2021
Editorial CommentJeffrey M Holzbeierlein
Urologic Oncology|May 29, 2021
Perioperative optimization of the genitourinary oncology patientJeffrey M Holzbeierlein
The Urologic Clinics of North America|April 14, 2018
Current Management of Invasive Bladder and Upper Tract Urothelial CancerJeffrey M Holzbeierlein
Urology Practice|June 14, 2023
Editorial CommentaryJeffrey M Holzbeierlein
Urologic Oncology|September 2, 2009
Review of the bylaws changes from the Society of Urologic Oncology 2009Jeffrey M Holzbeierlein
The Urologic Clinics of North America|June 26, 2024
Advances in Penile and Testicular Cancer: Promising Horizons in Clinical CareJeffrey M Holzbeierlein, Philippe E Spiess
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Urology|February 10, 2025
Reply: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 AmendmentJeffrey M Holzbeierlein
Nature Clinical Practice. Oncology|November 1, 2007
What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?Jeffrey M Holzbeierlein
The Urologic Clinics of North America|April 25, 2006
Managing complications of androgen deprivation therapy for prostate cancerJeffrey M Holzbeierlein
Cancer|January 26, 2011
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancerJeffrey M Holzbeierlein
The Journal of Urology|August 11, 2021
Editorial CommentJeffrey M Holzbeierlein
Urologic Oncology|May 29, 2021
Perioperative optimization of the genitourinary oncology patientJeffrey M Holzbeierlein
The Urologic Clinics of North America|April 14, 2018
Current Management of Invasive Bladder and Upper Tract Urothelial CancerJeffrey M Holzbeierlein
Urology Practice|June 14, 2023
Editorial CommentaryJeffrey M Holzbeierlein
Urologic Oncology|September 2, 2009
Review of the bylaws changes from the Society of Urologic Oncology 2009Jeffrey M Holzbeierlein
The Urologic Clinics of North America|June 26, 2024
Advances in Penile and Testicular Cancer: Promising Horizons in Clinical CareJeffrey M Holzbeierlein, Philippe E Spiess
Pageof 9